ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 86 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,036,522 | -28.7% | 12,346,417 | +15.6% | 0.46% | -46.6% |
| Q1 2024 | $16,881,088 | +76.1% | 10,684,233 | -11.6% | 0.86% | +170.8% |
| Q4 2023 | $9,584,924 | +12.1% | 12,086,915 | +10.3% | 0.32% | +4.2% |
| Q3 2023 | $8,551,263 | +18.3% | 10,963,158 | +40.3% | 0.31% | -7.0% |
| Q2 2023 | $7,226,588 | +22.0% | 7,812,528 | +43.7% | 0.33% | -1.8% |
| Q1 2023 | $5,924,629 | -23.2% | 5,435,439 | +2.9% | 0.34% | -37.0% |
| Q4 2022 | $7,714,113 | +49.8% | 5,283,639 | +10.3% | 0.53% | +6.0% |
| Q3 2022 | $5,149,000 | -35.3% | 4,789,490 | +2.4% | 0.50% | -39.8% |
| Q2 2022 | $7,955,000 | -12.8% | 4,679,491 | +5.6% | 0.83% | -28.9% |
| Q1 2022 | $9,125,000 | +12.5% | 4,429,491 | +104.8% | 1.17% | +9.2% |
| Q4 2021 | $8,109,000 | – | 2,162,313 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 5,555,461 | $5,416,574 | 2.98% |
| NEA Management Company, LLC | 17,079,778 | $16,651,076 | 1.25% |
| EcoR1 Capital, LLC | 27,404,070 | $26,716,228 | 0.82% |
| MPM BioImpact LLC | 5,095,912 | $4,968,514 | 0.77% |
| PFM Health Sciences, LP | 10,520,231 | $10,256,173 | 0.51% |
| Long Focus Capital Management, LLC | 12,346,417 | $12,036,522 | 0.46% |
| Matrix Capital Management Company, LP | 38,974,185 | $37,995,933 | 0.29% |
| Acuitas Investments, LLC | 541,201 | $527,617 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 1,743,619 | $1,699,854 | 0.17% |
| Key Client Fiduciary Advisors, LLC | 263,989 | $257,363 | 0.13% |